138 related articles for article (PubMed ID: 9229320)
21. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
de Gramont A; Louvet C; Krulik M
J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
[TBL] [Abstract][Full Text] [Related]
22. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
23. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
26. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
[TBL] [Abstract][Full Text] [Related]
27. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effect of sequential doses of methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced gastric cancer: comparison of intermediate-dose MTX with high-dose MTX].
Akazawa S; Nakajima T; Kitagawa H; Nakagawa T; Kanda Y; Futatsuki K; Suda Y; Yoshida S; Honda T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):91-8. PubMed ID: 3966810
[TBL] [Abstract][Full Text] [Related]
30. [Infusiontherapy with 5-fluorouracil ("infusional" 5-FU) in solid tumors].
Wilke H; Stahl M; Köster W; Vanhöfer U
Med Klin (Munich); 2000 Jun; 95 Suppl 1():3-8. PubMed ID: 10941246
[TBL] [Abstract][Full Text] [Related]
31. [Sequential methotrexate and 5-fluorouracil].
Sasaki T
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
[TBL] [Abstract][Full Text] [Related]
32. Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
Leichman CG; Benedetti JK; Zalupski MM; Hochster H; Shields AF; Lenz HJ; Wade Iii JL; Bearden Iii JD; Macdonald JS
Clin Colorectal Cancer; 2005 Jul; 5(2):119-23. PubMed ID: 16098253
[TBL] [Abstract][Full Text] [Related]
33. Weekly chronomodulated 48 h infusion of high-dose 5-fluorouracil modulated by methotrexate and (6S)-leucovorin in advanced colorectal cancer: a phase IB study.
Punt CJ; Kamm YL; Wagener DJ
Anticancer Drugs; 1997 Jun; 8(5):454-8. PubMed ID: 9215607
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic drug monitoring of 5-fluorouracil after its administration in high-dose protocols].
Boisdron-Celle M; Le Guellec C;
Therapie; 2010; 65(3):171-6. PubMed ID: 20699067
[TBL] [Abstract][Full Text] [Related]
36. Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello GP; Casaretti R; Montella M; Frasci G; Perna M; Comella G
Eur J Cancer; 1996 Sep; 32A(10):1719-26. PubMed ID: 8983280
[TBL] [Abstract][Full Text] [Related]
37. Low dose sequential methotrexate and 5-fluorouracil administration is effective and safe as neo-adjuvant chemotherapy in oral cancer.
Asaumi J; Nishijima K
In Vivo; 1996; 10(6):559-62. PubMed ID: 8986464
[TBL] [Abstract][Full Text] [Related]
38. Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B; Jakobsen A; Graf W; Berglund A; Gadeberg C; Hansen P; Kjaer M; Brunsgaard N; Sandberg E; Lindberg B; Sellström H; Lorentz T; Påhlman L; Gustavsson B
Eur J Cancer; 1998 Apr; 34(5):674-8. PubMed ID: 9713273
[TBL] [Abstract][Full Text] [Related]
39. Protracted infusion of 5-FU with weekly low-dose cisplatin as second-line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy.
Ahlgren JD; Trocki O; Gullo JJ; Goldberg R; Muir WA; Sisk R; Schacter L
Cancer Invest; 1991; 9(1):27-33. PubMed ID: 2012994
[TBL] [Abstract][Full Text] [Related]
40. 5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer.
Rougier P; Paillot B; LaPlanche A; Morvan F; Seitz JF; Rekacewicz C; Laplaige P; Jacob J; Grandjouan S; Tigaud JM; Fabri MC; Luboinski M; Ducreux M
Eur J Cancer; 1997 Oct; 33(11):1789-93. PubMed ID: 9470834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
